ResMed (RMD)

Revenue

$5.65B

TTM · Period ending: · USD

RMD logo

RMD Revenue

Latest reported$5.65B
RMD TTM Revenue ($10.90M → $5.65B)
High-resolution chart · PNG

RMD revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ResMed Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
5,653,443,000
5,537,789,000
5,398,119,000
5,257,400,000
5,146,327,000
5,021,529,000
4,926,773,000
4,807,485,000
4,685,297,000
4,584,159,000
4,504,077,000
4,375,020,000
4,222,993,000
4,015,673,000
3,763,275,000
3,624,405,000
3,578,126,000
3,539,492,000
3,443,759,000
3,348,896,000
3,196,825,000
3,091,065,000
3,091,753,000
3,027,899,000
2,957,011,000
2,891,632,000
2,784,405,000
2,699,348,000
2,606,571,000
2,525,238,000
2,454,644,000
2,404,817,000
2,340,197,000
2,273,252,000
2,195,822,000
2,124,946,000
2,066,737,000
2,028,698,000
1,968,373,000
1,892,516,000
1,838,713,000
1,773,130,000
1,741,748,000
1,710,160,000
1,678,912,000
1,641,059,000
1,616,320,000
1,577,709,000
1,554,972,000
1,554,368,000
1,540,191,000
1,532,387,000
1,514,456,000
1,471,778,000
1,437,270,000
1,393,471,000
1,368,514,000
1,338,478,000
1,302,662,000
1,275,910,000
1,243,148,000
1,192,827,000
1,158,229,000
1,127,377,000
1,092,357,000
1,052,744,000
1,001,950,000
949,796,000
920,735,000
903,927,000
887,889,000
867,588,000
835,397,000
791,555,000
762,718,000
738,467,000
716,332,000
696,195,000
675,485,000
643,473,000
606,995,000
561,248,000
507,422,000
464,899,000
425,505,000
392,971,000
375,794,000
354,193,000
339,338,000
327,142,000
304,861,000
287,862,000
273,570,000
249,122,000
232,902,000
216,533,000
204,076,000
194,857,000
184,761,000
170,203,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.